In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Corcept Therapeutics Inc’s stock clocked out at $69.90, up 13.60% from its previous closing price of $61.53. In other words, the price has increased by $13.60 from its previous closing price. On the day, 1.88 million shares were traded. CORT stock price reached its highest trading level at $70.6 during the session, while it also had its lowest trading level at $62.3.
Ratios:
To gain a deeper understanding of CORT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 51.36. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.70. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 10 ’25 when Swisher Daniel N JR sold 2,200 shares for $50.54 per share. The transaction valued at 111,188 led to the insider holds 0 shares of the business.
Swisher Daniel N JR bought 2,200 shares of CORT for $111,188 on Jan 10 ’25. On Jan 02 ’25, another insider, Maduck Sean, who serves as the insider of the company, sold 20,000 shares for $50.39 each. As a result, the insider received 1,007,800 and left with 85,318 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 7323772416 and an Enterprise Value of 6073269248. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 55.59, and their Forward P/E ratio for the next fiscal year is 36.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.65 while its Price-to-Book (P/B) ratio in mrq is 11.46. Its current Enterprise Value per Revenue stands at 9.662 whereas that against EBITDA is 42.15.
Stock Price History:
The Beta on a monthly basis for CORT is 0.57, which has changed by 1.8512511 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, CORT has reached a high of $62.98, while it has fallen to a 52-week low of $20.84. The 50-Day Moving Average of the stock is 25.08%, while the 200-Day Moving Average is calculated to be 71.07%.
Shares Statistics:
It appears that CORT traded 916.86K shares on average per day over the past three months and 821690 shares per day over the past ten days. A total of 104.70M shares are outstanding, with a floating share count of 90.10M. Insiders hold about 14.01% of the company’s shares, while institutions hold 81.37% stake in the company. Shares short for CORT as of 1736899200 were 16258254 with a Short Ratio of 17.73, compared to 1734048000 on 15715773. Therefore, it implies a Short% of Shares Outstanding of 16258254 and a Short% of Float of 21.790001.